TRANSIENT VISUAL SYMPTOMS ASSOCIATED WITH MELLARIL MEDICATION
Abstract
A case is presented in which a patient complained bitterly of blurring of vision when coming in from out of doors while receiving Mellaril and after having received approximately 30 grams of Mellaril over a period of 2½ months. The visual complaint cleared over a period of approximately 4 weeks after the Mellaril had been stopped. It is suggested that this is an early toxic reaction to Mellaril of the type seen previously with an experimental phenothiazine called NP-207.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
